Q98443367

Summary

Q98443367 is an interpellation^[1].

Key Facts

• Q98443367 authored Cecilia Wikström^[2].
• Q98443367's instance of is recorded as interpellation^[3].
• Q98443367's part of the series is recorded as interpellations of the 2002/03 legislative session of the Riksdag^[4].
• Q98443367's language of work or name is recorded as Swedish^[5].
• Q98443367 was published on +2003-05-08T00:00:00Z^[6].
• Q98443367's significant event is recorded as debate^[7].
• Q98443367's main subject is medication^[8].
• Q98443367's work available at URL is recorded as http://data.riksdagen.se/dokument/GQ10334^[9].
• Q98443367's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GQ10334^[10].
• Q98443367's applies to jurisdiction is recorded as Sweden^[11].
• Q98443367's legal citation of this text is recorded as ip. 2002/03:334^[12].
• Q98443367's title is recorded as läkemedelslistor^[13].
• Q98443367's addressee is recorded as Lars Engqvist^[14].
• Q98443367's maintained by WikiProject is recorded as Project Riksdagen's documents^[15].
• Q98443367's copyright status is recorded as public domain^[16].

Body

Definition and Type

Q98443367's instance of is recorded as interpellation^[3].